Endometrial cancer prognosis

The prognosis for endometrial cancer is generally favorable, especially when diagnosed at an early stage, with a five-year relative survival rate of approximately 81% for all stages combined. Outcomes for endometrial cancer depend heavily on the tumor's grade, histological subtype, and the extent of disease spread at the time of diagnosis.

How does prognosis vary by subtype and stage?

Prognosis for endometrial cancer is highly dependent on clinical staging. Early-stage (Stage I) disease, which is confined to the uterus, often has a five-year survival rate exceeding 90%. However, prognosis can vary significantly based on histology; for example, endometrioid adenocarcinomas typically have a better prognosis than rarer, more aggressive subtypes like serous or clear-cell endometrial cancer. Age of onset also plays a role, as younger patients may present with different tumor profiles, though they often tolerate intensive treatment regimens better than older populations.

What factors improve the prognosis of endometrial cancer?

Improving the outlook for endometrial cancer involves a combination of early detection and adherence to multidisciplinary care. Key factors include:

• Early Detection: Prompt investigation of postmenopausal bleeding leads to earlier stage diagnosis.


• Surgical Precision: Successful removal of the uterus, ovaries, and lymph nodes by a gynecologic oncologist.


• Adherence to Therapy: Completing recommended adjuvant treatments, such as radiation or chemotherapy, as prescribed.


• Lifestyle Factors: Maintaining a healthy weight and managing metabolic conditions like diabetes can support better recovery.

How has modern medicine improved outcomes?

Advances in molecular profiling have revolutionized the management of endometrial cancer. We now use genetic markers to categorize tumors, allowing for more personalized, targeted therapies and immunotherapy. These precision medicine approaches have significantly improved outcomes for patients with advanced or recurrent endometrial cancer compared to traditional chemotherapy alone.

Next steps

• Consult with a board-certified gynecologic oncologist to discuss your specific pathology report and treatment plan.


• Join our community of 31 members at DiseaseMaps.org to connect with others sharing their personal journeys with endometrial cancer.


• Maintain a rigorous follow-up schedule with your care team to monitor for any signs of recurrence.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• NIH National Cancer Institute (NCI) - Endometrial Cancer PDQ


• American Cancer Society - Survival Rates for Endometrial Cancer


• Orphanet - Rare Diseases Database


• Foundation for Women’s Cancer